Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Federico Cappuzzo et al.|Science Translational Medicine|2011Cited by 670
Eight‐year outcomes of aortic valve replacement with the Carpentier‐Edwards PERIMOUNT Magna Ease valveSteven Tsui, Rüdiger Lange, Michael Rosenbloom et al.|Journal of Cardiac Surgery|2022Cited by 13